The role of angiotensin II (Ang II) in the early embryonic development of the heart has not been examined. We have used RT-PCR to identify mRNA for angiotensinogen, angiotensin-converting enzyme, and the Ang II AT1 and AT2 receptors in embryonic day 10.25 Sprague-Dawley rats, and have used confocal microscopy to localize the AT1 receptor to the greater curvature of the developing ventricle in these animals at embryonic days (ED) 9.25 and 10.25. The antibodies used in immunolocalization studies did not distinguish between the AT1a and AT1b receptor subtypes. In whole embryo culture, Ang II added to the culture media resulted in increased ventricular growth and myocyte hypertrophy when treated embryos were compared to cultured littermate controls. Use of Losartan and PD123,319 to block the Ang II AT1 and AT2 receptors resulted in reduced ventricular development and cardiac dilation when compared to control and Ang II-treated embryos. Addition of Ang II and PD123,319 to the culture media also resulted in cardiac loop inversions which may be associated with disruption of normal myofibrillar development. These results clearly indicate an important role for Ang II in the early embryonic development of the heart. ᭧ 1997 Academic Press
INTRODUCTION
was inhibited by blocking the function of Ang II. Other in vivo evidence for the role of Ang II as a growth factor in The components of the renin-angiotensin system and intact fetal and neonatal hearts is primarily circumstantial. their roles in adult cardiac hypertrophy have been well docThese studies have shown changes in the temporal and spaumented and reviewed (Baker et al., 1992; Dzau, 1995;  tial localization of Ang II receptors or receptor mRNA in Holtz, 1993; Katz, 1994; Lorell, 1995) . In adult hearts, invarious regions of the developing rat heart as embryos increased hemodynamic load results in increased levels of crease in age from ED 11 (Shanmugam et al., 1994a ) through angiotensin II (Ang II) that stimulates significant hypertro-ED 19 (Sechi et al., 1992 (Sechi et al., , 1993 Shanmugam et al., 1994a,b) phy and remodeling of cardiac structure via increases in and up to 10 days after birth (Sechi et al., 1992 (Sechi et al., , 1993 ; Shanintracellular protein levels and interstitial collagens. These mugam et al., 1994a; Suzuki et al., 1993) . No information remodeling effects of Ang II are receptor mediated and two is available concerning the role of Ang II as a growth factor primary types of receptors, AT1 and AT2, have been identiin the early embryonic development of the rat heart prior fied (Sechi et al., 1992 (Sechi et al., , 1993 Shanmugam et al., 1994a,b) .
to ED 11. Currently, the majority of known effects of Ang II in the Data from experimentation with isolated myocytes and heart are mediated via subtypes of the AT1 receptor fibroblasts from late fetal and early neonatal hearts also (Guthrie, 1995; Kohout and Rogers, 1995) .
support the role of Ang II as a growth factor. Results from Recent evidence from in vivo studies indicates that Ang these studies pertinent to this report indicate that: (1) Ang II also acts as a growth factor and has a potential role in II stimulates the hypertrophy of myocytes (Aceto and Baker, late fetal and neonatal development of the heart. Beinlich 1990; Baker and Sadoshima et al., 1993) ; (2) et al. (1993, 1995) found that Ang II is required for the mechanical stress causes the release of Ang II directly from normal neonatal cardiac development of pigs by blocking cardiac myocytes which acts as an initial mediator of the the effects of angiotensin-converting enzyme and the Ang stretch induced hypertrophic response of myocytes (Sadoshima et al., 1993) ; (3) both the AT1 and AT2 Ang II receptor II AT1 receptor. In these studies, neonatal cardiac growth nate method (Chomczynski and Sacchi, 1987) . RT-PCR was per- subtypes are present in the heart and are developmentally formed with the GeneAmp RNA PCR kit (Perkin-Elmer, Norwalk, regulated (Sechi et al., 1992 (Sechi et al., , 1993 CT) using 2 mg of total RNA per reaction. Briefly, Moloney murine 1993a; Suzuki et al., 1993; Kojima et al., 1994; leukemia virus RT and random primers were used for cDNA synet al., 1995) ; and (4) activation of the AT1 Ang II receptor thesis from RNA. The cDNA was amplified with AmpliTaq DNA subtype mediates hypertrophy of cardiac myocytes via actipolymerase and primers for the rat aortic vascular smooth muscle vation of the immediate-early genes c-fos and c-myc, and Ang II type 1 receptor. Specific cDNA sequences used are shown the late response genes for actin and myosin heavy chains in Table 1 . Primer Detective software (Clontech, La Jolla, CA) was (Yamazaki et al., 1993; Sadoshima and Izumo, 1993b; Sado- used to select the Ang II primers. These primers were synthesized shima et al., 1995) .
by the Oligonucleotide Synthesis Facility at the University of South Carolina (Institute for Biological Research Technology, Columbia, Given the above evidence that Ang II is a potential growth SC). Primers for b-actin (Clontech) were used to test the integrity factor that may affect cardiac development, we initiated of the RNA. Thermal cycling was carried out for 30 cycles at 95ЊC studies to determine the effects of Ang II on early heart for 1 min, 60ЊC for 1 min, and 72ЊC for 30 s. Amplification of the development in the rat embryo. Specifically, we have: (1) appropriate DNA was verified by separation of RT-PCR products examined the in vivo expression and distribution of the Ang on 2% agarose gels along with PCR DNA markers (Promega Corp., II AT1 receptor subtype from embryonic days (ED) 9.25 and Madison, WI) for size reference. Gels were stained with 10 mg/ 10.25; (2) utilized the whole-embryo culture system to deml ethidium bromide and photographed against UV light with a termine the effects of exogenous Ang II on the rate of myoPolaroid camera. Controls were included that omitted the reverse cyte differentiation and heart development; and (3) used transcriptase from the RT reactions to ensure that RNA and not Losartan and PD123,319, which are specific blockers of the contaminating DNA was amplified. RT-PCR in the absence of reverse transcriptase resulted in no amplification of contaminating AT1 and AT2 receptor subtypes, respectively, to determine DNA with any of the primers used in these studies. Treatment of their effects on cardiac development in whole-embryo cul-RNA samples with RNase-free DNase followed by RT-PCR reture.
sulted in the amplification of the appropriate products.
MATERIALS AND METHODS

Whole Embryo Culture
Methods for whole embryo culture have been published pre-
Reagents
viously (Price et al., 1992; Nakagawa et al., 1997) and are similar Unless noted, reagents for whole-embryo culture, immunocytoto those originally described by New (1978) and modified by Sadler chemistry, and RT-PCR analyses were purchased from Sigma et al. (1982) . Age and developmentally matched embryos selected Chemical Co. (St. Louis, MO) and those for electron microscopy for culture were transferred with intact visceral yolk sacs into culwere from Polysciences, Inc., (Warrington, PA).
ture bottles containing 4.0 ml of rat serum and 1.0 ml of Tyrode's solution (0.137 M NaCl, 2.7 mM KCl, 3.6 mM NaH 2 PO 4 H 2 O, 27 mM d-glucose, 3.6 mM NaHCO 3 , 1.36 M CaCl 2 , 0.5 mM MgCl 2 ,
Animals
and 0.13 mM streptomycin). For each mother, 2-3 embryos were designated as controls. The remaining embryos in the litter were Time-pregnant Sprague-Dawley rats were obtained from Harlan designated for a treatment group. Ang II was added to the culture Laboratory (Indianapolis, IN). Day 0 of pregnancy was considered media at concentrations of 500 pg/ml, 10 ng/ml, or 10 mg/ml, Losarmidnight of the overnight breeding period. Animals were housed tan was added at concentrations of 1, 10, or 100 mg/ml, and in a facility approved by the American Association for Accredita-PD123,319 was added at 3, 30, or 300 nM. Control cultures contion of Laboratory Animal Care with food and water ad libitum. tained no Ang II, Losartan, or PD123,319. Following 24 h in culture, All experimental protocols were approved by the University Instithe culture medium was replaced with fresh medium containing tutional Animal Care and Use Committee.
Ang II, Losartan, or PD123,319 as described above. After designated times in culture, embryos were removed, scored by Brown and Fabro's (1981) morphological scoring system, and prepared for con-
RT-PCR
focal and transmission electron microscopy as described below. To determine at what developmental stage Ang II may be expressed and play a role in cardiac myocyte development, we performed RT-PCR analyses for angiotensinogen, angiotensin-con-
Confocal Scanning Laser and Transmission
verting enzyme, and the AT1 and AT2 receptors using isolated
Electron Microscopy
hearts from embryos that had developed for 10.25 days in vivo. Angiotensinogen, the precursor molecule for Ang II, was used to Embryos allowed to develop in vivo and in culture were rinsed in Tyrode's solution with 50 mM KCl to relax the heart, preserved determine the potential for the presence of Ang II. Since Ang II is a product of the renin-angiotensinogen cascade, mRNA for Ang II in 2% paraformaldehyde and stained for confocal microscopy (Price et al., 1996) . To visualize general heart morphology, selected emdoes not exist. Attempts to isolate cardiac tissue for RT-PCR at earlier time points in development resulted in the inclusion of bryos (ED 9.25-10) were stained in a 1:20 dilution of rhodamine phalloidin (Molecular Probes, Eugene, OR) in phosphate-buffered some noncardiac tissue.
After the appropriate gestational period, hearts were carefully saline plus 0.02% sodium azide (PBS-A) overnight at 4ЊC. Rhodamine phalloidin is a specific stain for f-actin, a primary component removed from 10 to 15 embryos and pooled. Total RNA was isolated from the pooled hearts by the one-step guanidinium thiocyaof the developing cardiac contractile apparatus. To facilitate pene- tration of rhodamine phalloidin and imaging of larger hearts, emon the SDS gels in relation to molecular weight standards. The relative amounts of MHC and actin in the various treatment groups bryos older than ED 10 were encased in 13% polyacrylamide gel using a modification of the procedure described by Hansen and are expressed as a percentage of that present in untreated control embryos. Dryer (1981) . After fixation, embryos were rinsed in PBS-A and placed in polyacrylamide gel that was immediately polymerized with 2% ammonium persulfate. Polyacrylamide gel encased em-
Morphometry and Statistical Analyses
bryos were sectioned at 200 mm with an Oxford vibratome and sections were stained with rhodamine phalloidin.
For comparative measurements of treated and control animals, For labeling of Ang II AT1 receptors, either whole embryos or embryos were photographed at 151 on an Olympus dissecting miacrylamide sections of embryos were incubated in a 1:20 dilution of croscope. Photographic negatives were projected via a Dage MTI a polyclonal antibody to the AT 1 receptors (Chemicon International CCD72 camera to an Image 1 system (Universal Imaging, West Inc., Temecula, CA) for 24 h at 4ЊC, rinsed in PBS-A, and stained Chester, PA) and measurements of ventricular length and width overnight at 4ЊC in a 1:50 dilution of FITC. For double labeling, were obtained from the projected image. Ventricular length was embryos were first labeled for the AT1 receptors followed by rhodadetermined as the distance from the apex to the base of the ventricle mine phalloidin. Controls consisted of either nonimmune IgG or and ventricular width was measured as the distance across the PBS buffer substituted for the primary antibody. Antibodies for plane of the ventricle with the greatest diameter (Nakagawa et al., the detection of AT2 receptors are not available. All embryos and 1997). sections were examined using a Bio-Rad MRC 1000 CSLM.
To determine changes in cardiac growth associated with a speFor TEM, embryos were rinsed in Tyrode's solution with 50 mM cific treatment, measurements of ventricular length and width for KCl and processed as previously described (Price et al., 1996) . the control embryos of a litter were made and an average value for each parameter was obtained. The average value from the control embryos was then used to compare variations in cardiac growth of the treated embryos from the same litter. Each treatment group
Protein Accumulation
consisted of embryos from at least three mothers and a minimum To determine the effects of angiotensin, Losartan, and sample size of six embryos per group. Changes in cardiac growth, PD123,319 on actin and myosin heavy chain levels in the heart, expressed as a percentage of the control, are presented both as raw, embryos were cultured for 48 h in the presence of 10 mCi/ml of or actual increases in growth, and as normalized data against the [ 35 S]methionine. Following culture, embryos were rinsed in iceoverall increase in embryo crown-rump length (Nakagawa et al., cold Moscona's saline (136.8 mM NaCl, 28.6 mM KCl, 11.9 mM 1997). Data from all whole embryo culture runs were then pooled NaHCO 3 , 9.4 mM glucose, 0.08 mM NaH 2 PO 4 , pH 7.4) and the and t tests were performed to determine differences in the means hearts were removed and transferred to an Eppendorf tube conof the control and treated populations. taining ice-cold 10% tricholoracetic acid (TCA). Hearts were centriTo compare the proportions of the control and treated populafuged at 15,000g at 4ЊC for 15 min, rinsed in 10% TCA, and again tions in which cardiac inversions occurred, the method of Sokal centrifuged. The TCA supernatants were discarded and the precipiand Rohlf (1969) to test the equality of population percentages was tated tissue was solubilized in 30 ml of SDS gel loading buffer (62.5 used. mM Tris-HCl, 5.0% b-mercaptoethanol, 10% glycerol, 8.0% SDS, pH 6.8) and boiled for 10 min. Samples were stored at 020ЊC until analyzed. For analysis, samples were boiled for an additional 5 min
RESULTS
and a 5-ml aliquot was removed for scintillation counting. An equal number of radioactive counts were loaded on a 10% SDS-poly-
In Vivo Expression and Localization of the AT1
acrylamide gel and the concentrations of biosynthetically labeled Receptor and Angiotensinogen mRNA actin and MHC were determined as previously described (Simpson Using RT-PCR, mRNA for angiotensinogen, angiotenet al., 1996) . Bands corresponding to actin (43 kDa) and MHC (206 kDa) were identified by calculating the relative mobility of proteins sin-converting enzyme, and the AT1 and AT2 receptor sub-
FIG. 1.
RT-PCR products showing the expression of mRNA for b-actin used as a control and the AT1 and AT2 receptors, angiotensinogen, and angiotensin-converting enzyme at in vivo embryonic day 10.25. The expression of these mRNAs from isolated hearts identifies the potential for an active angiotensin system in the early embryonic heart. types was detected from the isolated hearts of ED 10.25
Ang II to the culture media increases at a greater rate than overall growth of the embryo. animals (Fig. 1 ). Although it was not possible to isolate cardiac tissue from animals younger than ED 10.25, localSince the effects of Ang II on cardiac growth in whole embryo culture were not as pronounced in the cultures of ization of the AT1 receptor by confocal microscopy was possible at ED 9.25. In animals at this stage of development, ED 10.25 animals, receptor blocking experiments were carried out only on ED 9.25 animals maintained in culture for AT1 receptor localization was confined to the right side of the heart in the area associated with the initial formation 48 h. Experiments with Losartan, a specific blocker for the AT1 receptor, again resulted in significantly larger hearts of the ventricular loop ( Fig. 2A) . AT1 receptor localization continued to be restricted to the greater curvature of the at the three concentrations tested (Figs. 4A and 4B).
Blocking of the AT2 receptors with PD123,319 also resulted ventricular loop through ED 10.25 (Fig. 2B ) and was subsequently found throughout the embryonic heart by ED 11.25 in larger hearts at the highest concentration (300 nM) used (Figs. 4A and 4B) . Combining the highest concentrations of (not shown). At higher magnifications, AT1 receptor localization was detected in the majority of cardiac cells in both Losartan (100 mg/ml) and PD123,319 (300 nM) also resulted in a significant increase heart size. the developing myo-and pericardium (Fig. 2C) , and when localized on myocyte membranes the AT1 receptor labeling pattern was similar to that of sarcomeric banding of devel-
Morphological Assessment of the Effects of Ang II,
oping myofibrils (Fig. 2D) .
Losartan, and PD123,319 on Cardiac Development in Whole Embryo Culture Effects of Ang II, Losartan, and PD123,319 on
Myocardial development provides a potential explanation
Ventricular Length and Width in Whole Embryo
for the apparent paradox of increased heart size in response Culture to both the increasing concentrations of available Ang II and the blocking of the Ang II receptors. Figures 5A-5D The addition of Ang II to the culture media of embryos isolated at ED 9.25 and cultured for 48 h significantly inshow rhodamine phalloidin-stained confocal images taken from a control embryo (A) and embryos treated with 10 mg/ creased both the ventricular length and width of treated hearts at the three concentrations of Ang II used. At ED ml of AngII (B), 100 mM Losartan (C), or 300 nM PD123,319 (D). All images are single optical sections taken from com-10.25 plus 48 h in culture, the actual increases in cardiac growth were not as pronounced and were significant only parable areas near the caudal portion of the ventricular loop. The myocardium and developing trabeculae of the Ang IIat the higher concentrations of Ang II that were added to the culture media (Figs. 3A and 3B ). The decrease in the treated embryo showed the greatest intensity of staining for f-actin, which indicates that the increased ventricular observed effect of Ang II on cardiac growth as the embryos increased in age and size may be a result of reduced quantilength and width may be due to cardiac hypertrophy. Transmission electron micrographs (Figs. 6A and 6B) comparing ties of Ang II reaching the heart via diffusion through the body wall, and the potential for an increased number of myofibrillar development in similar areas of the ventricular walls of control and Ang II-treated embryos also indicated available Ang II receptors in the body wall and other organs binding Ang II before it diffuses to the cardiac region.
that myofibrillar development was more advanced in Ang II-treated embryos than in controls. Definitive sarcomeres To test if increases in heart growth were simply in response to increases in overall body size and development, and well-developed Z-bands were frequently found in the Ang II-treated embryos, but were rarely observed in control cardiac growth was normalized against an overall increase in body size (crown-rump length) in response to Ang II embryos. Conversely, rhodamine phalloidin staining of the myocartreatment. The majority of data points tested remained significant at the P°0.05 test level (Figs. 3A and 3B ). This dium of the Losartan-treated embryo showed that the myocardial wall in many areas was a single myocyte layer thick indicates that cardiac growth in response to the addition of
FIG. 2. (A-D)
Colocalization of the Ang II AT1 receptor antibody (green) and f-actin (red) in embryonic hearts. Images are stacked confocal Z-series projected dorsal to ventral which results in the right side of the heart being viewed as the left side of the image. In the ED 9.25 heart (A), the Ang II AT1 receptor is localized primarily on the right side (arrow) in the region of the presumptive ventricle. This is also the region in which myofibrillogenesis is first initiated. At ED 10.25 (B), AT1 receptor antibody localization continues to be greatest along the greater curvature of the developing ventricle (arrow). Receptor localization is also heavy in the developing membranes of the body wall at both embryonic stages (*). In the area of the greater curvature of the ventricle, the AT1 receptor antibody was localized on the membranes of a majority of the cells in the developing epi-and myocardium (C), and was closely associated with the Z-bands of the developing myofibrils (arrows, D). Scale bars, 100 mm for A and B; 25 mm for C and D. appeared to be less extensive than in the control and Ang II-treated embryos (Figs. 5A-5D ). This indicates that the observed increase in ventricular length and width associated with Losartan and PD123,319 treatment may be a result of cardiac dilation in response to reduced myofibrillar tension in the developing heart wall.
Biochemical Assessment of Cardiac Actin and Myosin Heavy Chain (MHC) Accumulation in response to Ang II, Losartan, and PD123,319
As expected from the morphological observations, both actin and MHC levels significantly increased when ED
FIG. 3. (A) Effect of Ang II on ventricular length. (B) Effect of Ang
II on ventricular width. Bars labeled as actual are direct comparisons of heart size in experimental versus control embryos. Normalized data are a ratio of the heart size and crown-rump length of an embryo to account for the overall increase in growth of embryos in response to Ang II. The addition of Ang II significantly increased the actual ventricular lengths and widths of hearts at all three concentrations tested. When normalized against increased body size, the higher concentrations of 10 ng/ml and 10 mg/ml of Ang II added to the culture media also increased heart size. For ED 9.25, sample sizes are 25, 7, 24, and 30 for controls, 500 pg/ml, 10 ng/ ml, and 10 mg/ml, respectively. For ED 10.25, sample sizes are 26, 7, 16, and 25 for the respective test groups. Asterisk indicates hearts are significantly larger than those of control embryos (P°0.05). (Figs. 5A-5C ). Although dissignificant increases in the heart size of ED 9.25 embryos cultured tinct myofibrils were present in the developing trabeculae for an additional 48 h. In contrast to increased cardiac size due to and myocardial wall, development of f-actin did not appear hypertrophy in the presence of Ang II, blocking the Ang II receptors to be as extensive in the heart of the Losartan-treated emincreased heart size as a result of cardiac dilation. Sample sizes are bryo as in the control and Ang II-treated embryos. Although 29, 6, 6, 6, 14, 9, 11, 11 for the respective test groups indicated on not as distinct, development of f-actin in the trabeculae the X axis. Asterisk indicates significantly different than control embryos P°0.05).
and myocardial wall of the PD123,319-treated embryo also Copyright ᭧ 1997 by Academic Press. All rights of reproduction in any form reserved.
FIG. 5. (A-D)
Single optical sections collected with the confocal microscope from the caudal region of the ventricular loop in embryos allowed to develop 9.25 days in vivo and an additional 48 h in culture and stained for f-actin with rhodamine phalloidin. Developing myofibrils were found in control embryos (A), and embryos were treated with 100 mg/ml of Ang II (B), 100 mM Losartan (C), and 300 nM PD123,319 (D). However, actin development appeared to be more extensive in the control (A) and Ang II (B)-treated embryos than in the embryos treated with Losartan (C) and PD123,319 (D). In addition, the wall of the developing myocardium (arrows) in control (A) and Ang II (B)-treated embryos consisted of multiple layers of cells, whereas areas of the myocardial wall of the Losartan-treated embryo (C) were frequently a single myocyte thick (arrow). Scale bar, 25 mm.
10.25 embryos were treated with 10 mg/ml of Ang II for 48 control embryos. This may again be related to the biochemical assessment utilizing the entire heart, whereas the morh in culture (Fig. 7) . However, Ang II did not significantly increase the levels of these contractile proteins in the ED phological assessment of development focused on the specific areas in which the AT1 receptor was found. 9.25 embryos cultured for 48 h. This may be a result of the limited distribution of the Ang II AT1 receptor in the heart during the initial period of culture ( Fig. 2A) . The biochemi-
Cardiac Inversions Associated with Angiotensin II,
cal assay used included the entire heart and may not have When treated with Ang II and PD123,319, embryos that had been allowed to develop for 9.25 days in vivo and 48 h in embryos. Treatment of embryos with either 100 mM Losartan or 30 nM PD123,319 resulted in a large degree of variculture also exhibited an increased frequency of cardiac inversions in which the ventricular loop developed to the left rather ability between culture runs and levels of actin and MHC that were not significantly different from those found in than to the right (Fig. 8) . No other characteristics of disrupted . Embryos were allowed to develop for 9.25 days in vivo followed by 48 h in culture. Myofibrillar development in the Ang II-treated embryo was more extensive and sarcomere and Z-band organization were more advanced than in control embryos. Scale bar, 10 mM. left-right symmetry in body development, including abnormal tail curvature, were observed in Ang II-treated embryos ( Table 2) . Addition of Ang II to the culture media of embryos is present as early as ED 10.25 in the rat, and localization that were allowed to develop for 10.25 days in vivo and 48 h of the AT1 receptor was observed by confocal microscopy in culture did not result in the development of cardiac inverat ED 9.25. Hunt et al. (1995) have previously used autoradisions as looping patterns were established prior to culture. ography to localize Ang II receptors in the myocardium of ED 14 rats and to identify temporal variations in the density
DISCUSSION
of the receptors through fetal and neonatal development.
In Vivo Expression of the Angiotensinogen System
Others (Sechi et al., 1992 (Sechi et al., , 1993 Matsubara et al., 1994;  Components Shanmugam et al., 1994a,b) have also shown temporal and RT-PCR of isolated hearts indicates that message for the spatial variations in the expression of both the AT1 and necessary components of a local cardiac angiotensin system AT2 receptor subtypes during late fetal, early neonatal, and adult development, but did not examine early embryonic cardiac expression of the receptors. During myocardial development, the total density of Ang II receptors peaks during neonatal development and subsequently decreases in the adult (Sechi et al., 1992) , although subsequent changes in receptor density have been noted in cases of ventricular hypertrophy (Lopez et al., 1994) .
Effects of Exogenous Angiotensin II and Specific Receptor Blockers during Cardiac Development
Identification of mRNA for the various components of the angiotensinogen system and immunolocalization of the AT1 receptor in the embryonic heart does not indicate that the system is functional at this early stage in development. to play a significant role in the early growth and developthe normal development of cardiac looping (Brown and Wolpert, 1990; Beddington, 1996) . ment of the embryonic heart. The increase in cardiac inversions in response to either increased levels of Ang II or the Normal myofibrillar differentiation has previously been identified as a requirement for the development of dextral blocking of the AT2 receptor with PD123,319 also indicates that a proper balance between Ang II levels and receptor looping patterns in the embryonic heart. Most hypotheses that attempt to explain cardiac looping involve phenomena function is required for normal cardiac morphogenesis.
Studies with isolated cardiac myocytes have also indisuch as right side dominance in development of myocytes at the base of the heart tube (Itasaki et al., 1989 (Itasaki et al., , 1991 ; Price cated that the addition of Ang II to the culture media results in myocyte hypertrophy (Aceto and Baker, 1990; Baker and et al., 1996) , specific pattern formation of myofibrils and components of the extracellular matrix in different layers Miyata and Haneda, 1994; Sadoshima and Izumo, 1993a) and an increase in the rate and force of myoand regions of the myocardium (Manasek, 1981; Manasek et al., 1984; Shiraishi et al., 1992 Shiraishi et al., , 1995 Itasaki et al., 1989 , cyte contraction (Abdellatif et al., 1991 Rogers et al., 1989; Kohout and Rogers, 1995) . In isolated cardiac myocytes, the 1991; Price et al., 1996) , and mechanical tension on myocytes in the greater curvature of the heart tube as it loops binding of Ang II to the AT1 receptors initiates a phosphotyrosine cascade that activates protein kinase C and the (Taber et al., 1995) . During loop formation, cell number does not change significantly (Manasek, 1981) , but cells expression of the immediate early genes c-fos and c-myc, and the late response genes for actin and myosin (Sadoshima along the greater curvature of the loop flatten and increase their apical surface area, while cells in the lesser curvature and Izumo, 1993b; Sadoshima et al., 1995; Yamazaki et al., 1993 Yamazaki et al., , 1995a . These studies provide additional evidence that do not undergo this shape change (Manasek et al., 1984) . Concurrent with changes in phenotype, myofibrils in the Ang II has the potential to increase the rate of myofibrillogenesis as we observed in whole embryo culture, and to convex area of the heart loop develop more rapidly than in the concave portions of the myocardium (Itasaki et al., induce cardiac hypertrophy that would result in the increases in the ventricular length and width we observed in 1991; Price et al., 1996) . The right side, or convex area, of the developing heart these experiments.
Blocking the function of the AT1 receptor by the addition loop is also the region in which the Ang II AT1 receptor is predominantly found in ED 9.25 and 10.25 hearts. In vitro of Losartan blocks the hypertrophic response of isolated neonatal cardiac myocytes to Ang II (Sadoshima and Izumo, studies with isolated cardiac myocytes have indicated a direct relationship between mechanical stress and the role 1993a; Sadoshima et al., 1995) , normal hypertrophy of the neonatal left ventricle (Beinlich et al., 1993 (Beinlich et al., , 1995 , and of Ang II in cardiac myocyte hypertrophy (Sadoshima and Izumo, 1993c; Sadoshima et al., 1993; , pathological hypertrophy of the left ventricle in response to increases in cardiovascular pressure (Rockman et al., 1995a,b) . These studies indicate that mechanical stress stimulates the secretion of Ang II from cardiac myocytes 1994; de Gasparo et al., 1994) . Similarly, the addition of Losartan to the whole embryo culture media resulted in and that Ang II mediates mechanical load-induced cardiac myocyte hypertrophy. This may, in part, explain the more decreased ventricular development as indicated by the relatively thin myocardial walls and an apparent reduction in advanced cellular and myofibrillar development in the greater curvature of the ventricular loop (Manasek et al. , the development of distinct myofibrils in the ventricular myocardium and trabeculae. A similar, but less pronounced , 1984 Itasaki et al., 1991; Shiraishi et al., 1992 Shiraishi et al., , 1995 Price et al., 1996) . effect on ventricular development was observed when the AT2 receptors were blocked by the addition of PD123,319.
However, in previous studies in which myofibrillogenesis was disrupted by the addition of cytochalasin D crystals at the right base of the heart, polymerization of actin filaments Angiotensin and Cardiac Looping in this area was prevented (Itasaki et al., 1991) . This resulted in myofibrils on the left side of the heart being more adCardiac looping is a complex process that is dependent on a number of genetic and physical factors that may be vanced than those on the right side, and a 100% occurrence of cardiac inversions. The concentration of AT1 receptors affected by Ang II. It has previously been reported that the addition of Ang II to the culture media of isolated cardiac on the right side of the heart, and the addition of Ang II to the culture media, should result in an increased rate of fibroblasts increases the autocrine production of transforming growth factor-b1 (TGF-b1) in isolated neonatal carmyofibrillogenesis in this area which is essentially the opposite of the results from the studies by Itasaki et al. (1991) . diac fibroblasts (Lee et al., 1995; Sharma et al., 1994) . Initial expression of two members of the TGF-b1 subfamily, nodal
This apparent inconsistency is difficult to explain, but the disruption of normal myofibrillar patterns in the developing and lefty, is also asymmetric in the early embryo (Collignon et al., 1996; Meno et al., 1996) . Both are transiently found heart is a contributing factor to abnormal cardiac looping. Whole embryo culture has previously been used to idenon the left side of the embryo and disruption of nodal expression results in cardiac positioning defects. The asymmetric tify other factors, including receptor-mediated adrenergic stimulation, that induces situs inversus and an associated distribution and possible interactions of these growth factors with Ang II indicate that subsequent asymmetric high incidence of cardiac inversions (Fujinaga and Baden, 1991a,b) . Of particular interest is that both adrenergic and changes in protein accumulation levels may be critical in Bobik, A., Grinpukel, S., Little, P. J., Grooms, A., and Jackman, G. angiotensin receptors are coupled to G-proteins that, when (1990) . Angiotensin and noradrenalin increase PDGF BB receptors activated, induce an increase in intracellular calcium levels and potentiate PDFG BB stimulated DNA synthesis in vascular (Miyata and Haneda, 1994; Fujinaga et al., 1994 also affects the development and function of cardiac fibroDelisee, C., Schaeffer, P., Cazaubon, C., and Chatelain, P. (1993).
blasts (Dostal et al., 1992; Schorb et al., 1993 1994; Schatteman et al., 1996) . We have recently initiated Dzau, V. J. (1995) . Molecular biology of angiotensin II biosynthesis and receptors. Can. J. Cardiol. 11(Suppl. F), 21F-26F.
whole embryo culture studies to further examine these inFujinaga, M., and Baden, J. M. (1991a). Evidence for an adrenergic teractions and their potential role in cardiac differentiation.
mechanism in the control of body asymmetry. Dev. Biol. 143, 203-205. Fujinaga, M., and Baden, J. M. (1991b) . Critical period of rat develop-
